Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets. | Front Pharmacol | 2021 | 33935756 | PubTator, text mining | PubMed |
| Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer. | Front Immunol | 2021 | 33927719 | PubTator, text mining | PubMed |
| FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. | Cells | 2021 | 33924474 | PubTator, text mining | PubMed |
| Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting. | Diagnostics (Basel) | 2021 | 33924134 | PubTator, text mining | PubMed |
| What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype. | Int J Mol Sci | 2021 | 33922532 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer. | Cancers (Basel) | 2021 | 33916719 | PubTator, text mining | PubMed |
| Identification of Expression Patterns and Potential Prognostic Significance of m5C-Related Regulators in Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2021 | 33912441 | PubTator, text mining | PubMed |
| Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival. | NPJ Precis Oncol | 2021 | 33911192 | PubTator, text mining | PubMed |
| Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion. | Stat Med | 2021 | 33906263 | PubTator, text mining | PubMed |
| Reduced Arene Complexes of Hafnium Supported by a Triamidoamine Ligand. | Angew Chem Int Ed Engl | 2021 | 33890350 | PubTator, text mining | PubMed |
| Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes. | Mol Cancer Res | 2021 | 33883185 | PubTator, text mining | PubMed |
| Residential PM2.5 exposure and the nasal methylome in children. | Environ Int | 2021 | 33872926 | PubTator, text mining | PubMed |
| Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study. | Front Oncol | 2021 | 33869057 | PubTator, text mining | PubMed |
| Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma. | Cancer Cell Int | 2021 | 33865387 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Signalling in the Diseased Nervous System. | Mol Neurobiol | 2021 | 33860438 | PubTator, text mining | PubMed |
| MACRODONTIA: A brief overview and a case report of KBG syndrome. | Radiol Case Rep | 2021 | 33854669 | PubTator, text mining | PubMed |
| Antibiotics and Antibiotic Resistance Genes in Animal Manure - Consequences of Its Application in Agriculture. | Front Microbiol | 2021 | 33854486 | PubTator, text mining | PubMed |
| From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression. | Front Oncol | 2021 | 33828987 | PubTator, text mining | PubMed |
| Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies. | Int J Mol Sci | 2021 | 33810118 | PubTator, text mining | PubMed |
| The Role of Cancer-Associated Fibroblasts in Tumor Progression. | Cancers (Basel) | 2021 | 33808627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=34